Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | HBB | P68871 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 7/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2463315 | 1.00 | ALDH1A1 (0.50) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A | |
| SCHEMBL36452 | 0.92 | CYP2A6 (0.48) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A | |
| SCHEMBL27905829 | 0.89 | CYP2A6 (0.46) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A | |
| SCHEMBL27838385 | 0.89 | CYP2A6 (0.46) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A | |
| SCHEMBL1178667 | 0.85 | CYP2A6 (0.37) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A | |
| SCHEMBL28217476 | 0.85 | ALOX5 (0.40) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A | |
| SCHEMBL27922290 | 0.82 | CYP2A6 (0.46) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A | |
| SCHEMBL21644746 | 0.82 | CYP2A6 (0.46) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A | |
| Benz(B)Anthracene SCHEMBL3474922 | 0.78 | ALDH1A1 (0.61) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A | |
| Benz(B)Anthracene SCHEMBL22352910 | 0.78 | ALDH1A1 (0.61) | ALDH1A1HSD17B10TDP1CYP3A4HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024002966-A1 | HYDROPHILIC PHENALENONES AND THEIR USE IN ANTIMICROBIAL PHOTODYNAMIC THERAPY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-01-04 | — | — | WO | claimed |
| EP-4299131-A1 | HYDROPHILIC PHENALENONES AND THEIR USE IN ANTIMICROBIAL PHOTODYNAMIC THERAPY | Centre national de la recherche scientifique (FR) | 2024-01-03 | — | — | EP | claimed |
| EP-4393935-A1 | METHOD FOR PRODUCING 2?-MODIFIED GUANOSINE COMPOUND | Nissan Chemical Corporation (JP) | 2024-07-03 | — | — | EP | disclosed |
| CN-118076620-A | Process for producing 2' -modified pyrimidine nucleoside | 日产化学株式会社 | 2024-05-24 | — | — | CN | disclosed |
| CN-117858884-A | Process for producing 2' -modified guanosine compound | 日产化学株式会社 | 2024-04-09 | — | — | CN | disclosed |
| WO-2024002966-A1 | HYDROPHILIC PHENALENONES AND THEIR USE IN ANTIMICROBIAL PHOTODYNAMIC THERAPY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-01-04 | — | — | WO | disclosed |
| EP-4299131-A1 | HYDROPHILIC PHENALENONES AND THEIR USE IN ANTIMICROBIAL PHOTODYNAMIC THERAPY | Centre national de la recherche scientifique (FR) | 2024-01-03 | — | — | EP | disclosed |
| US-11834421-B2 | Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof | JAPAN TOBACCO INC. (JP) | 2023-12-05 | — | — | US | disclosed |
| CN-111741948-B | Saturated ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof | 日本烟草产业株式会社 | 2023-11-10 | — | — | CN | disclosed |
| EP-3760619-B1 | SATURATED RING-CONDENSED DIHYDROPYRIMIDINONE OR DIHYDROTRIAZINONE COMPOUND, AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC (JP) | 2023-10-25 | — | — | EP | disclosed |
| WO-2023054708-A1 | METHOD FOR PRODUCING 2' MODIFIED PYRIMIDINE NUCLEOSIDE | 日産化学株式会社 | 2023-04-06 | — | — | WO | disclosed |
| WO-2008043846-A2 | NEW ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES | UNIBIOSCREEN SA (BE) | 2008-04-17 | — | — | WO | disclosed |
| EP-1180765-B1 | Optical recording medium and porphycene compound | MITSUI CHEMICALS INC (JP) | 2005-04-06 | — | — | EP | disclosed |
| EP-1180765-A1 | Optical recording medium and porphycene compound | Mitsui Chemicals, Inc. (JP) | 2002-02-20 | — | — | EP | disclosed |
| US-6248918-B1 | BIS(DIHYDROCARBYLPHOSPHINOYLALKYL)-1,1'-BINAPHTHOL) AND RARE EARTH OR GROUP 3A METAL SALTS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-4965163-A | ETHYLENE-ALKYL ACRYLATE POLYMER CARRIERS | FUJI PHOTO FILM CO., LTD. (JP) | 1990-10-23 | — | — | US | disclosed |
| US-4783562-A | Process for the preparation of trichloromethyl-substituted aromatic compounds, and trichloromethyl-substituted aromatic compounds obtained in this process | BAYER AKTIENGESELLSCHAFT (DE) | 1988-11-08 | — | — | US | disclosed |
| EP-0061029-B1 | PROCESS FOR THE PREPARATION OF TRICHLOROMETHYL-SUBSTITUTED AROMATIC COMPOUNDS | BAYER AG (DE) | 1986-01-08 | — | — | EP | disclosed |
| US-4500740-A | Hydrolysis of water-insoluble organic halides | UOP INC. (US) | 1985-02-19 | — | — | US | disclosed |
| EP-0061029-A1 | Process for the preparation of trichloromethyl-substituted aromatic compounds | BAYER AG (DE) | 1982-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834421-B2 | Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof | RORC, RORB, RORA | ALDH1A1 252/4885HSD17B10 155/4885TDP1 4547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.